Atlas Trials

Nimotuzumab Combined With Chemoradiotherapy Versus Chemoradiotherapy for Local Advanced Cervical Squamous Cell Carcinoma

Clinical trial NCT04678791 · UNKNOWN

Trial details

NCT number
NCT04678791
Sponsor
Peking University Third Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Cervical Squamous Cell Carcinoma
Start date
2020-12-01
Primary completion
2024-12-01
Enrollment
286

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.